Thymosin-alpha1 promotes the apoptosis of regulatory T cells and survival rate in septic mice

Frontiers in Bioscience

Volumn 16, Issue 7, 2011, Pages 3004-3013

  Wan, Jian ^a,b   Shan, Yi ^a,c   Shan, Hongwei ^a   Li, Guomin ^b   Wang, Tao ^a   Guan, Jun ^a   Liu, Xuefeng ^a   Chen, Dechang ^a   Li, Wenfang ^a   Lin, Zhaofen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c 306 HOSPITAL OF PLA   (China)

Author keywords

Apoptosis; inflammatory cytokine; Immunodulation; Mouse; Regulatory T cells; Sepsis; Survival Rate; Thymosin alpha1

Indexed keywords

MUS;

CYTOKINE; DRUG DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; IMMUNOLOGIC FACTOR; THYMOSIN; THYMOSIN ALPHA1;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; DISEASE MODEL; DRUG EFFECT; ILEUM; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; REGULATORY T LYMPHOCYTE; SEPSIS; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; APOPTOSIS; CYTOKINES; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; ILEUM; IMMUNOLOGIC FACTORS; MICE; SEPSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; THYMOSIN;

EID: 79959551122     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3894     Document Type: Article

References (34)

1. R. P. Dellinger, M. M. Levy, J. M. Carlet, J. Bion, M. M. Parker, R. Jaeschke, K. Reinhart, D. C. Angus, C. Brun-Buisson, R. Beale, T. Calandra, J. F. Dhainaut, H. Gerlach, M. Harvey, J. J. Marini, J. Marshall, M. Ranieri, G. Ramsay, J. Sevransky, B. T. Thompson, S. Townsend, J. S. Vender, J. L. Zimmerman and J. L. Vincent: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med, 34(1), 17-60 (2008)
2. H. Gao, T. W. Evans and S. J. Finney: Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter? Crit Care, 12(3), 213 (2008)
3. A. Lever and I. Mackenzie: Sepsis: definition, epidemiology, and diagnosis. BMJ, 335(7625), 879-83 (2007) (Pubitemid 350069465)
4. D. Rittirsch, M. A. Flierl and P. A. Ward: Harmful molecular mechanisms in sepsis. Nat Rev Immunol, 8(10), 776-87 (2008)
5. T. A. Dernaika and G. T. Kinasewitz: Heparin in the treatment of severe sepsis: a new look at an old therapy. Crit Care Med, 36(11), 3098-9 (2008)
6. T. Cardoso, A. H. Carneiro, O. Ribeiro, A. Teixeira-Pinto and A. Costa-Pereira: Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care, 14(3), R83 (2010)
7. C. Amabile-Cuevas: Antibiotic resistance in Mexico: a brief overview of the current status and its causes. J Infect Dev Ctries, 4(3), 126-31 (2010)
8. A. Melamed and F. J. Sorvillo: The burden of sepsisassociated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Crit Care, 13(1), R28 (2009)
9. D. J. Minnich and L. L. Moldawer: Anti-cytokine and anti-inflammatory therapies for the treatment of severe sepsis: progress and pitfalls. Proc Nutr Soc, 63(3), 437-41 (2004) (Pubitemid 39145504)
10. J. C. Marshall, E. Charbonney and P. D. Gonzalez: The immune system in critical illness. Clin Chest Med, 29(4), 605-16, vii (2008)
11. N. R. Webster and H. F. Galley: Immunomodulation in the critically ill. Br J Anaesth, 103(1), 70-81 (2009)
12. S. M. Opal: The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol, 297(5), 365-77 (2007) (Pubitemid 47188050)
13. F. Venet, A. Pachot, A. L. Debard, J. Bohe, J. Bienvenu, A. Lepape and G. Monneret: Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25-lymphocytes. Crit Care Med, 32(11), 2329-31 (2004) (Pubitemid 39491817)
14. R. S. Hotchkiss and S. Opal: Immunotherapy for sepsis-a new approach against an ancient foe. N Engl J Med, 363(1), 87-9 (2010)
15. Y. Li, H. Chen, X. Li, W. Zhou, M. He, M. Chiriva-Internati, M. S. Wachtel and E. E. Frezza: A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1. J Intensive Care Med, 24(1), 47-53 (2009)
16. J. Pugin: Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp, 280, 21-7; discussion 27-36, 160-4 (2007)
17. A. Kessel, E. Bamberger, M. Masalha and E. Toubi: The role of T regulatory cells in human sepsis. J Autoimmun, 32(3-4), 211-5 (2009)
18. S. Sakaguchi, T. Yamaguchi, T. Nomura and M. Ono: Regulatory T cells and immune tolerance. Cell, 133(5), 775-87 (2008) (Pubitemid 351707693)
19. N. Askenasy, A. Kaminitz and S. Yarkoni: Mechanisms of T regulatory cell function. Autoimmun Rev, 7(5), 370-5(2008)
20. D. A. Vignali, L. W. Collison and C. J. Workman: How regulatory T cells work. Nat Rev Immunol, 8(7), 523-32 (2008)
21. P. Pandiyan, L. Zheng, S. Ishihara, J. Reed and M. J. Lenardo: CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol, 8(12), 1353-62 (2007) (Pubitemid 350131172)
22. L. Romani, F. Bistoni, C. Montagnoli, R. Gaziano, S. Bozza, P. Bonifazi, T. Zelante, S. Moretti, G. Rasi, E. Garaci and P. Puccetti: Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. Ann N Y Acad Sci, 1112, 326-38 (2007) (Pubitemid 47598643)
23. L. Romani, F. Bistoni, K. Perruccio, C. Montagnoli, R. Gaziano, S. Bozza, P. Bonifazi, G. Bistoni, G. Rasi, A. Velardi, F. Fallarino, E. Garaci and P. Puccetti: Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood, 108(7), 2265-74 (2006) (Pubitemid 44497509)
24. A. L. Goldstein: From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther, 9(5), 593-608 (2009)
25. M. F. Osuchowski, K. Welch, J. Siddiqui and D. G. Remick: Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol, 177(3), 1967-74 (2006) (Pubitemid 44092537)
26. G. Monneret, A. L. Debard, F. Venet, J. Bohe, O. Hequet, J. Bienvenu and A. Lepape: Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med, 31(7), 2068-71 (2003) (Pubitemid 36900766)
27. J. M. Kim: Molecular mechanisms of regulatory T cell development and suppressive function. Prog Mol Biol Transl Sci, 92, 279-314 (2010)
28. S. Kapoor: The rapidly expanding therapeutic role of thymosin alpha-1 in the management of gastrointestinal and systemic infectious disorders. J Intensive Care Med, 24(3), 210-1 (2009)
29. Q. Yao, L. X. Doan, R. Zhang, U. Bharadwaj, M. Li and C. Chen: Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes. Immunol Lett, 110(2), 110-20 (2007) (Pubitemid 46839137)
30. B. Pierluigi, C. D'Angelo, F. Fallarino, S. Moretti, T. Zelante, S. Bozza, A. De Luca, F. Bistoni, E. Garaci and L. Romani: Thymosin alpha1: the regulator of regulators? Ann N Y Acad Sci, 1194, 1-5 (2010)
31. N. Singh, M. Yamamoto, M. Takami, Y. Seki, M. Takezaki, A. L. Mellor and M. Iwashima: CD4(+)CD25(+) regulatory T cells resist a novel form of CD28-and Fasdependent p53-induced T cell apoptosis. J Immunol, 184(1), 94-104 (2010)
32. S. Hori, T. Nomura and S. Sakaguchi: Control of regulatory T cell development by the transcription factor Foxp3. Science, 299(5609), 1057-61 (2003) (Pubitemid 36222930)
33. A. Banz, C. Pontoux and M. Papiernik: Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J Immunol, 169(2), 750-7 (2002) (Pubitemid 34753430)
34. E. S. Yolcu, S. Ash, A. Kaminitz, Y. Sagiv, N. Askenasy and S. Yarkoni: Apoptosis as a mechanism of Tregulatory cell homeostasis and suppression. Immunol Cell Biol, 86(8), 650-8 (2008)